The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Molecular underpinnings of RB status as a biomarker of poor outcome in advanced prostate cancer.
 
Amy C. Mandigo
No Relationships to Disclose
 
Christopher McNair
No Relationships to Disclose
 
Kexin Ku
No Relationships to Disclose
 
Angel Pang
No Relationships to Disclose
 
Yi Fang Guan
No Relationships to Disclose
 
Jeff Holst
Employment - MetabBloQ
Leadership - MetabBloQ
Consulting or Advisory Role - MetabBloQ
 
Myles Brown
Consulting or Advisory Role - GTx; Novartis
Research Funding - Novartis
Patents, Royalties, Other Intellectual Property - As part of my work at the Dana-Farber Cancer Institute I have made invention disclosures and the institute is filing patents on technology related to endocrine resistance in breast cancer and improved CRISPR dual sgRNA library design.
Travel, Accommodations, Expenses - GTx
 
William Kevin Kelly
Honoraria - Constellation Pharmaceuticals; Janssen Oncology
Consulting or Advisory Role - Foundation Medicine; Sanofi
Research Funding - Bayer (Inst); Endocyte (Inst); Exelixis (Inst); Janssen Oncology (Inst); Novartis (Inst); Sanofi (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Janssen Oncology
 
Karen E. Knudsen
Stock and Other Ownership Interests - Genomic Health; Pfizer
Honoraria - CellCentric; Sanofi
Consulting or Advisory Role - Atrin Pharmaceuticals; CellCentric; Context Therapeutics; Sanofi
Research Funding - Celgene
Travel, Accommodations, Expenses - Genentech; Sanofi